Read the Clock Right: Mapping Regulatory Exclusivities for True Generic Drug Entry Timing
The Date That Actually Controls Generic Entry Walk into almost any pharmaceutical business development meeting, and the discussion of competitive […]
Win the Patent War Before the Drug Goes Generic: How Paragraph IV Challenges and Pay-for-Delay Settlements Decide Who Gets Paid — and Who Gets Blocked
The moment a pharmaceutical brand company files a new drug application with the FDA, a clock starts ticking. Somewhere across
Why Consumers Pay a “Trust Premium” for Branded Generics
How pharmaceutical companies engineer consumer psychology to extract billions from brand loyalty after patents expire — and what it means
Why Consumers Pay a “Trust Premium” for Branded Generics Read Post »
What AI Knows About Your Drug vs. Your Competitors
Pharmaceutical brand teams spend millions monitoring what doctors, patients, and payers say about their drugs. Most of that investment goes
What AI Knows About Your Drug vs. Your Competitors Read Post »
Read the Patent, Beat the Competition: The Intelligence Gap Most Pharma Teams Leave Open
Every pharmaceutical company files patents to protect its investment. Every one of those patents is a public document. And yet,
Read the Patent, Beat the Competition: The Intelligence Gap Most Pharma Teams Leave Open Read Post »
Two Systems, One Fight: How the Patent Dance and Orange Book Linkage Shape the $400 Billion Biologics War
The Fork in the Road That Determines Billions When a drug company files for FDA approval of a new medicine,
Find Expired Drug Patents Before Your Competitors Do
A complete operational guide to locating abandoned and lapsed pharmaceutical patents for generic market entry The Money Is in the
Find Expired Drug Patents Before Your Competitors Do Read Post »
Win the Market After the Patent Falls: ANDA and Suitability Petitions as Strategic Weapons
The Moment Everyone Prepares for and Nobody Fully Survives The day a blockbuster drug’s core patent expires is circled on
AI Is Your Drug’s New KOL — and You’re Not Tracking It
How chatbots became the most influential prescribing influencers in pharma, what happens when they get it wrong, and the monitoring
AI Is Your Drug’s New KOL — and You’re Not Tracking It Read Post »
